Pure Global

Leptospira IgG/IgM Antibody Rapid Test - India CDSCO Medical Device Registration

Leptospira IgG/IgM Antibody Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_8af0d8c7eac8d51bfb3b259ed0859622_72056b839406a2a27f5ed127d3e0f8b0. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Leptospira IgG/IgM Antibody Rapid Test
UID: MFG/IVD/2023/000113_8af0d8c7eac8d51bfb3b259ed0859622_72056b839406a2a27f5ed127d3e0f8b0

Brand Name

Chimera

Device Class

Class B

Approving Authority

South Delhi Division

Product Information

The Chimeraยฎ Leptospira IgG/IgM, Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to Leptospira interorgan in humanโ€™s whole blood, serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing